# Leadership, Planning and Evaluation

> **NIH NIH P30** · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · 2024 · $307,092

## Abstract

Abstract Leadership, Planning, and Evaluation
The senior leadership of the City of Hope Comprehensive Cancer Center (COHCCC) is composed of highly
qualified members who bring their respective strengths and unique backgrounds to drive the progress of the
center. It is led by Steven T. Rosen, MD, Director, Larry Kwak, MD, PhD, Deputy Director, and nine Associate
Directors in the domains of Basic Sciences, Clinical Sciences, Population Sciences, Health Equity, Community
Outreach and Engagement, Informatics and Computational Biology, Education and Training, Shared Resources,
and Administration. With their distinct qualifications, members have worked individually or in collaboration to
expand the center, reach new milestones, and further benefit our community.
COHCCC leadership has a wide array of advisory input to assist in planning for the Center's next steps and
evaluating the outcomes of Center programs and policy implementation. Internal advisors include Program and
Shared Resource leaders, oversight committees, and the chairs of clinical and research departments, all of
whom contribute to shaping our future direction through internal evaluation processes.
Our External Advisory Board continues to play a significant role in reviewing our strategic plans and advising on
our course of action. We have responded to their recommendations and by virtue of their guidance have
1) integrated the faculty and the shared / genomic resources of TGen within the COHCCC membership,
2) restructured and enhanced our Mass Spectrometry Shared Resource, 3) established the Department of
Diabetes and Cancer Metabolism, and 4) initiated the Integrated Drug Development Venture to accelerate
translation of scientific discoveries to first-in-human trials. External relationships are also fostered by Community
Outreach & Engagement, which has established partnerships between the scientific community and
organizations that support minority engagement.
Strategic planning is critical to the development of future programs that advance COHCCC priorities, detailing
how we will execute our unwavering commitment to drive paradigm shifts to more effectively prevent, diagnose,
and treat cancer. Because of the innovative structure of our institution as a stand-alone cancer center, we are
uniquely positioned to realize breakthrough advances in basic science, clinical trials, and patient care. COHCCC
engages in a 5-year strategic planning process involving many collaborating partners, including COHCCC
faculty, staff, patients, and stakeholders, each providing crucial input and valuable feedback. The approach
includes data collection and analysis, multiple interviews with key parties, and an iterative review and approval
process of the final deliverable. A new plan was launched in October 2021 with an emphasis on 1) Precision
Medicine, 2) Cellular Therapeutics, 3) Health Equity, and 4) Clinical Networks. Performance and progress of the
stated goals within the plan are tracked and catalogue...

## Key facts

- **NIH application ID:** 10843130
- **Project number:** 5P30CA033572-41
- **Recipient organization:** BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
- **Principal Investigator:** STEVEN Terry ROSEN
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $307,092
- **Award type:** 5
- **Project period:** 1997-08-01 → 2027-11-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10843130

## Citation

> US National Institutes of Health, RePORTER application 10843130, Leadership, Planning and Evaluation (5P30CA033572-41). Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/grant/nih/10843130. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*